Log In
Print
BCIQ
Print
Print this Print this
 

Aryplase, Naglazyme, galsulfase

Also known as: Arylsulfatase B, rhASB

  Manage Alerts
Collapse Summary General Information
Company BioMarin Pharmaceutical Inc.
DescriptionRecombinant human N-acetylgalactosamine-4-sulfatase
Molecular Target Not available
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationMucopolysaccharidosis
Indication DetailsTreat mucopolysaccharidosis VI (MPS VI)
Regulatory Designation

Partner

AnGes MG Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today